The New York Mets are navigating a tricky stretch of injuries as the season rolls on, and Tuesday brought a wave of updates from team president David Stearns and manager Carlos Mendoza ahead of their series opener against the Detroit Tigers.

Let's start with the biggest name: Francisco Lindor. The star shortstop is making progress, having shed the protective boot on his left foot as he recovers from a calf strain. More importantly, he's feeling better. The next step is a follow-up MRI in the coming days, which will help the medical staff map out a clear path back to the field. "We won't know until we see the results of the MRI," Stearns said. "We need to get it over the next 48 hours or so, and once we get that, we'll get our doctors to map out a plan." There's also some good news here: the team isn't concerned about any impact on Lindor's Achilles. He's been sidelined since April 23, so this cautious approach is all about making sure he's fully ready when he returns.

Now, onto the outfield, where the news is less encouraging. Luis Robert Jr. hasn't been progressing as hoped. The talented outfielder is still dealing with discomfort in his lower back, and Mendoza confirmed, "He's still showing some symptoms there." The Mets are now consulting with additional specialists, though there's no indication that surgery is on the table. Robert received an injection when he first landed on the IL two weeks ago, and the team initially expected a minimal absence. That timeline is now up in the air, and there's no update on when he might return.

In the infield, Jorge Polanco is facing a similar wait-and-see situation. He's been battling bursitis in his Achilles, and Stearns noted that the ankle "continues to show signs" of trouble. The key is getting it asymptomatic before Polanco can even think about working back into the lineup. "We have good days and then it flares up," Stearns explained. "We need to get the ankle asymptomatic so we know he can go out on a daily basis, run the bases freely, and we're not there yet." The team is following protocols from specialists, who haven't recommended shutting him down completely, but it's clear this is going to take some time.

For Mets fans, it's a mixed bag of cautious optimism and lingering concerns. Lindor's progress is a bright spot, but the extended timelines for Robert and Polanco mean the team will need to lean on its depth in the coming weeks. Keep an eye on those MRI results for Lindor—that could be the first domino to fall in a more positive direction.